Madras High Court Clarifies Bolar Exemption for Regulatory Approval Exports
The Madras High Court, in Novartis AG v. Venkata Narayana Active Ingredients, delivers a critical examination of the Bolar exemption under Section 107A. The ruling is pivotal for pharmaceutical manufacturers in navigating the evidentiary requirements for regulatory export approvals.


